Zawada Agnieszka, Rychter Anna Maria, Ratajczak Alicja Ewa, Lisiecka-Masian Agata, Dobrowolska Agnieszka, Krela-Kaźmierczak Iwona
Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355 Poznan, Poland.
Microorganisms. 2020 Dec 23;9(1):18. doi: 10.3390/microorganisms9010018.
More research has recently focused on the role of the gut microbiota in the development or course of numerous diseases, including non-communicable diseases. As obesity remains prevalent, the question arises as to what microbial changes are associated with increased obesity prevalence and what kind of prevention and treatment approaches it could provide. Moreover, the influence of the gut-brain axis on obesity is also crucial, since it can affect metabolism and food intake. The quantitative and qualitative changes in the microbiota composition are called dysbiosis; however, in view of the current knowledge, it is difficult to conclude which microbial imbalances are adverse or beneficial. Increased numbers of pathological microorganisms were observed among patients with obesity and comorbidities associated with it, such as diabetes, cardiovascular disease, and insulin resistance. Our review provides current knowledge regarding changes in the intestinal microbiota associated with obesity and obesity-associated comorbidities. Nevertheless, given that dietary patterns and nutrients are two of the factors affecting the intestinal microbiota, we also discuss the role of different dietary approaches, vitamins, and minerals in the shaping of the intestinal microbiota.
最近,更多的研究聚焦于肠道微生物群在包括非传染性疾病在内的多种疾病的发生发展过程中所起的作用。由于肥胖仍然普遍存在,因此出现了这样的问题:哪些微生物变化与肥胖患病率增加相关,以及它能提供何种预防和治疗方法。此外,肠道-脑轴对肥胖的影响也至关重要,因为它会影响新陈代谢和食物摄入。微生物群组成的定量和定性变化被称为生态失调;然而,鉴于目前的知识,很难断定哪些微生物失衡是有害的还是有益的。在肥胖患者以及与肥胖相关的合并症(如糖尿病、心血管疾病和胰岛素抵抗)患者中,观察到致病微生物数量增加。我们的综述提供了关于与肥胖及肥胖相关合并症有关的肠道微生物群变化的当前知识。尽管如此,鉴于饮食模式和营养素是影响肠道微生物群的两个因素,我们还讨论了不同饮食方法、维生素和矿物质在塑造肠道微生物群方面的作用。